Meda Sues Perrigo, Impax Over Generic Nasal Spray

Law360, New York (February 27, 2014, 3:29 PM EST) -- Meda Pharmaceuticals Inc. sued Perrigo Co. and Impax Laboratories Inc. on Wednesday, saying the generic-drug makers' plan to market and sell their own version of Meda's antihistamine spray Astepro would infringe the company's patent.

Meda alleged in a complaint filed in federal court in New Jersey that Perrigo and Impax's abbreviated new drug application would violate a patent for Astepro, U.S. Patent Number 8,518,919, titled, "Compositions comprising azelastine and methods of use thereof." The U.S. Patent and Trademark Office issued the patent on Aug. 27, 2013. ...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.